Pre-order Enquiry
Request Free Sample
Covid-19 Impact on Branded Generics Market, Global Research Reports 2020-2021
SKU ID : QYR-15658762 | Publishing Date : 12-May-2020 | No. of pages : 96
A branded generic is a drug that is bioequivalent to the original product, but is now marketed under another company's brand name. Branded generics are an attractive business for Valeant’s Emerging Markets operations as they enjoy low research and development costs and sustainable sales.
North America accounts for the largest market size of branded generics in 2017 and is projected to lead the market over the forecast period of 2018 to 2025.
This report provides a complete quantitative data and qualitative analysis on the global market for Branded Generics. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Branded Generics was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Branded Generics is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Branded Generics, including the following market information:
Global Branded Generics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Branded Generics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Branded Generics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Branded Generics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Key market players
Major competitors identified in this market include Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Oral
Parenteral
Topical
Other
Based on the Application:
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
North America accounts for the largest market size of branded generics in 2017 and is projected to lead the market over the forecast period of 2018 to 2025.
This report provides a complete quantitative data and qualitative analysis on the global market for Branded Generics. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Branded Generics was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Branded Generics is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Branded Generics, including the following market information:
Global Branded Generics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Branded Generics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Branded Generics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Branded Generics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Key market players
Major competitors identified in this market include Mylan NV, Novartis AG, Eva Pharmaceutical Industries, Pfizer, Sun Pharmaceutical Industries, Aspen Pharmacare Holding, Abbott Laboratories, Bausch Health, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Oral
Parenteral
Topical
Other
Based on the Application:
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
